BIOPHARMX CORP's ticker is BPMX and the CUSIP is 09072X101. A total of 18 filers reported holding BIOPHARMX CORP in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $648,000 | +36.1% | 1,283,951 | +0.9% | 0.17% | -4.5% |
Q4 2016 | $476,000 | +22.4% | 1,273,128 | +81.7% | 0.18% | +51.7% |
Q3 2016 | $389,000 | -14.5% | 700,636 | 0.0% | 0.12% | -23.9% |
Q2 2016 | $455,000 | -40.4% | 700,636 | 0.0% | 0.16% | -44.0% |
Q1 2016 | $764,000 | +35.7% | 700,636 | +89.0% | 0.28% | +48.9% |
Q4 2015 | $563,000 | +47.4% | 370,636 | 0.0% | 0.19% | +56.3% |
Q3 2015 | $382,000 | -59.7% | 370,636 | 0.0% | 0.12% | -56.9% |
Q2 2015 | $949,000 | – | 370,636 | – | 0.28% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Vivo Capital, LLC | 16,128,515 | $3,561,000 | 0.46% |
Virtu Financial LLC | 580,070 | $128,000 | 0.01% |
FRG Family Wealth Advisors LLC | 30,000 | $7,000 | 0.00% |
FRANKLIN RESOURCES INC | 9,749,615 | $2,153,000 | 0.00% |
GEODE CAPITAL MANAGEMENT, LLC | 671,686 | $148,000 | 0.00% |
MILLENNIUM MANAGEMENT LLC | 16,779 | $4,000 | 0.00% |
OPPENHEIMER & CO INC | 35,000 | $8,000 | 0.00% |
CREDIT SUISSE AG/ | 50,003 | $11,000 | 0.00% |
MORGAN STANLEY | 100 | $0 | 0.00% |
Invesco Ltd. | 51,964 | $11,000 | 0.00% |